DOG1 utility in diagnosing gastrointestinal stromal tumors on fine‐needle aspiration
Open Access
- 11 March 2011
- journal article
- research article
- Published by Wiley in Cancer Cytopathology
- Vol. 119 (3) , 202-208
Abstract
BACKGROUND: Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of the gastrointestinal (GI) tract, and the majority contain KIT or PDGFRA activating mutations. Fine‐needle aspiration biopsy (FNAB) is a valuable technique in the diagnosis of GIST and may allow for preoperative therapy with tyrosine kinase inhibitors (TKI). Because of the morphologic diversity of these tumors, routine diagnosis of GIST often relies on C‐Kit immunohistochemical staining in addition to morphologic findings. However, up to 15% of GISTs are C‐Kit negative. Antibodies with increased sensitivity and specificity for detection of C‐Kit–negative GIST cases may be of value, especially because some of these cases may also benefit from TKI therapy.METHODS: Immunohistochemical staining for DOG‐1, C‐Kit (CD117) and protein kinase C theta (PKCθ) was performed on FNA cell‐block preparations representing 30 GISTs, 17 leiomyosarcomas, 16 melanomas, 16 schwannomas, 11 adenoid cystic carcinomas, and 8 leiomyomas.RESULTS: DOG‐1 was found to have 100% sensitivity and 100% specificity in diagnosis of GIST. C‐Kit demonstrated 70% sensitivity and 76% specificity, and PKCθ showed 40% sensitivity and 86% specificity. When only spindle‐cell neoplasms were considered (adenoid cystic carcinomas excluded), the specificity of C‐Kit increased to 89%. Of interest, all C‐Kit–negative cases showed DOG‐1 positivity.CONCLUSIONS: DOG‐1 was the most sensitive and specific of the 3 markers for the diagnosis of GIST in cell‐block preparations and may be of particular use in the diagnosis of C‐Kit–negative GIST. Cancer (Cancer Cytopathol) 2011;. © 2011 American Cancer SocietyKeywords
This publication has 28 references indexed in Scilit:
- DOG1 Antibody in the Differential Diagnosis of Gastrointestinal Stromal TumorsAmerican Journal of Surgical Pathology, 2009
- Mutation assay of the novel gene DOG1 in gastrointestinal stromal tumors (GISTs)Journal of Gastroenterology, 2008
- Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostainingJournal of Clinical Pathology, 2008
- Expression of KIT (CD117) in Neoplasms of the Head and Neck: An Ancillary Marker for Adenoid Cystic CarcinomaLaboratory Investigation, 2003
- Validating Immunohistochemical Staining for KIT (CD117)American Journal of Clinical Pathology, 2003
- PDGFRA Activating Mutations in Gastrointestinal Stromal TumorsScience, 2003
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002
- Extragastrointestinal (Soft Tissue) Stromal Tumors: An Analysis of 48 Cases with Emphasis on Histologic Predictors of OutcomeLaboratory Investigation, 2000
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998
- A YAC Contig Spanning a Cluster of Human Type III Receptor Protein Tyrosine Kinase Genes (PDGFRA-KIT-KDR) in Chromosome Segment 4q12Genomics, 1994